This is the authors' abstract. We don't add key points for this paper.
The new European Directive 2013/59/EURATOM requires that patients are informed about the risk associated with ionising radiation and that detailed information on patient exposure is included in the radiological report. This implies a revision of the routinely used dose indexes to obtain quantities related to individual exposure evaluable from acquisition parameters. Here we propose a new mammography dose index consistent with the average glandular dose (AGD). An equation has been developed for calculating the average absorbed breast dose (2ABD). It depends on incident air kerma k a,i and on energy absorption coefficient μen; k a,i can be calculated for each anode-filter combination, based on kVp, mAs, the yield of the tube used Y tb , and the breast thickness d; μ en depends on kVp and has been evaluated for each anode-filter combination. 2ABD has been compared to AGD evaluated by Dance or Wu methods, which represent the reference standards, for 20 patients of our university hospital. The incident air kerma k a,i , calculated as a function of kVp, mAs, Y tb and d, was in good agreement with the same quantity directly measured: the relative uncertainty is < 0.10. The results of the comparison between 2ABD and AGD evaluated by both Dance and Wu methods appear to be consistent within the uncertainties. 2ABD is easily evaluable for each mammogram from the acquisition parameters. It can be proposed as a new suitable dose index, consistent with AGD, matching the requirements of the 2013 European Directive.
No takes yet. Share an insight, caveat, or question.
Traino et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: